Transaction

Emkan Capital and Partners' Investment in Aumet's Operations for USD 12 million

Announced
13 May 2026
Target
Aumet, Inc
Value
$12m
Asset class
Venture Capital
Type
Investment
Instrument
Ordinary Shares (Equity)
Lead investors
Emkan Capital
Investors
Emkan Capital, Cigalah Group, Shorooq Partners, Right Side Capital Management, LLC, AAIC Investment Pte. Ltd., Qatar Development Bank (QDB), SABAH VC, Salehiya Trading Company
Sector
Healthcare / Health Care Administration
Markets
Egypt

About the target

Aumet, Inc. is a United States-incorporated healthtech company, operationally headquartered in Riyadh, Saudi Arabia, that develops and operates an AI-powered procurement operating system for the healthcare sector. Founded in 2016 and initially based in Mountain View, California, the company provides three tiered SaaS products, Pulse for individual pharmacies, Chain for multi-branch pharmacy groups, and Enterprise for hospitals and national health systems, that integrate inventory management, marketplace functionality, and AI-driven procurement automation. Aumet connects pharmacies, pharmaceutical manufacturers, distributors, and healthcare providers into a unified digital procurement network. As of May 2026, the platform serves over 12,000 pharmacies across Saudi Arabia, Jordan, and Egypt; operates across 32 hospitals, 500+ medical centres, and 18+ medical warehouses in Jordan; and has processed more than USD 1 billion in gross merchandise value (GMV). The company's Enterprise solution has been deployed through Jordan's Ministry of Health in collaboration with Abu Dhabi-based AI firm Presight, a subsidiary of G42.

Sources

  1. www.wamda.com
  2. Partner Researchers